ENPP2 and fatty liver disease: In this context, experimental evidence has shown that adipose-specific deletion of autotaxin reduces circulating lysophosphatidic acid but enhances diet-induced adiposity [39], while recent clinical data demonstrated that serum ATX levels are positively associated with metabolic-associated fatty liver disease and hyperuricemia in postmenopausal women [40].